Investigating the potential effects of a nutraceutical formulated with Limosilactobacillus fermentum, quercetin, and resveratrol on the fecal microbiota of healthy and hypertensive subjects

This study aims to evaluate the effects of a potential nutraceutical product composed of three strains of Limosilactobacillus (L.) fermentum, quercetin, and resveratrol on the intestinal microbiome of healthy and hypertensive subjects.